Open an account

Concord Medical Services Holdings

CCM · NYSE

$4.06+$0.5599 (+16.00%)TodayMarket closed ·
Prev close $3.50

About CCM

Concord Medical Services Holdings Ltd. engages in the provision of operation of radiotherapy and diagnostic imaging centers. The company is headquartered in Beijing, Beijing and currently employs 595 full-time employees. The company went IPO on 2009-12-11. The firm operates its business through two segments. The Network segment is engaged in providing enterprise customers with integrated oncology-related solutions, including primarily the supply, management and technical support for medical equipment and software solutions, and providing equipment leasing and comprehensive support services. The Hospital segment is engaged in providing a full spectrum of oncology healthcare services to cancer patients across the entire care continuum through its self-owned cancer hospitals and clinics. The firm mainly conducts its business in the domestic market.

Employees
595
Headquarters
Beijing, Beijing
Listed
Dec 11, 2009
Sector
Health Care
Industry
Health Care Providers & Services
Website
concordmedical.com

CCM key statistics

Market cap
15.20M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
15.84K
Volume
22.23K
Open price
$3.64
High today
$4.06
Low today
$3.64
52 Week high
$6.80
52 Week low
$2.79

Concord Medical Services Holdings (CCM) at a glance

Concord Medical Services Holdings (CCM) last traded at $4.06, with a market cap of 15.20M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $3.64 and $4.06. The current price is 11.5% above the day's low and 0.0% below its high.

Volume so far is 22.23K shares, above the average of 15.84K shares a day.

Over the past year Concord Medical Services Holdings has ranged from $2.79 to $6.80, and now sits 32% of the way up that range.

Concord Medical Services Holdings met or beat analyst EPS estimates in 4 of the last 8 quarters. In Q2 FY16 it reported -$0.60 per share against an estimate of $2.12.

CCM earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 4 of the last 8 quarters, by 241.2% on average.

  1. Q3 FY14: reported $1.20 per share against an estimate of $0.707
  2. Q4 FY14: reported $1.00 per share against an estimate of $1.31
  3. Q1 FY15: reported $1.10 per share against an estimate of $0.707
  4. Q2 FY15: reported $1.30 per share against an estimate of $0.202
  5. Q3 FY15: reported $0.80 per share against an estimate of $0.202
  6. Q4 FY15: reported -$3.70 per share against an estimate of -$0.909
  7. Q1 FY16: reported -$1.10 per share against an estimate of $1.21
  8. Q2 FY16: reported -$0.60 per share against an estimate of $2.12

CCM news

  • 12 Health Care Stocks Moving In Tuesday's After-Market Session

  • Press releasePRNewswire

    Concord Medical Files Annual Report on Form 20-F for the Fiscal Year 2025

  • Press releasePRNewswire

    Concord Medical Schedules 2025 Annual Meeting of Shareholders

  • Avi Kapoor

    Olema Pharmaceuticals, Exelixis, Genmab And Other Big Stocks Moving Lower In Monday's Pre-Market Session

  • Press releasePRNewswire

    Concord Medical Reports Financial Results for the First Half of 2025

  • Press releasePRNewswire

    Concord Healthcare Announces Completion of China's First Proton Therapy for Choroidal Malignant Melanoma

  • Press releasePRNewswire

    Concord Healthcare Announces Official Release of the Proton Therapy Large Model

  • Press releasePRNewswire

    Concord Medical Files Annual Report on Form 20-F for Fiscal 2024

Similar companies

Companies in the same industry as Concord Medical Services Holdings

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.